OPNT - Opiant Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
7/30/2017
7/30/2016
Total Revenue
37,613
13,982
18,446
9,898
Cost of Revenue
15,153
15,216
-
-
Gross Profit
22,460
-1,234
-
-
Operating Expenses
Research Development
9,578
8,479
3,172
1,747
Selling General and Administrative
12,325
11,478
8,182
15,889
Total Operating Expenses
21,903
19,957
11,353
17,636
Operating Income or Loss
558
-21,190
7,093
-7,738
Interest Expense
-
-
4
12
Total Other Income/Expenses Net
-77
-98
18
-64
Income Before Tax
950
-21,144
7,131
-7,814
Income Tax Expense
-39
51
550
0
Income from Continuing Operations
989
-21,195
6,581
-7,814
Net Income
989
-21,195
6,581
-7,814
Net Income available to common shareholders
989
-21,195
6,581
-7,814
EBITDA
-
-21,188
7,140
-7,800